Rampertab Shameze serves as Executive at Zomedica Pharmaceuticals Corp., where they oversee executive responsibilities. Since joining the company, Rampertab Shameze has executed 17 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 22, 2024 involved selling 595,372 shares valued at $0.
Rampertab Shameze currently holds 416,288 shares of Zomedica Pharmaceuticals Corp. (ZOM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rampertab Shameze has been a net neutral trader of ZOM stock. They have purchased $0 and sold $0 worth of shares.
Rampertab Shameze's most recent insider trade was on Aug 22, 2024, when they sold 595,372 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.25 |
| Discretionary |
| Apr 21, 2024 | ASXC | $0 | Option Exercise | 81,521 | $N/A | Discretionary |
| Feb 4, 2024 | ASXC | $0 | Option Exercise | 280,909 | $N/A | Discretionary |
| Feb 4, 2024 | ASXC | $40.6K | Payment | 150,367 | $0.27 | Discretionary |
| Jul 1, 2023 | ASXC | $3.6K | Payment | 6,975 | $0.51 | Discretionary |
| Jul 1, 2023 | ASXC | $0 | Option Exercise | 16,666 | $N/A | Discretionary |
| Feb 4, 2023 | ASXC | $78.0K | Payment | 103,998 | $0.75 | Discretionary |
| Feb 4, 2023 | ASXC | $0 | Option Exercise | 248,512 | $N/A | Discretionary |
| Jul 1, 2022 | ASXC | $2.7K | Payment | 7,015 | $0.38 | Discretionary |
| Jul 1, 2022 | ASXC | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Feb 4, 2022 | ASXC | $0 | Option Exercise | 98,608 | $N/A | Discretionary |
| Feb 4, 2022 | ASXC | $21.4K | Payment | 26,711 | $0.80 | Discretionary |
| Jul 1, 2021 | ASXC | $13.4K | Payment | 4,558 | $2.93 | Discretionary |
| Jul 1, 2021 | ASXC | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Mar 12, 2018 | ZOM | $35.2K | Option Exercise | 176,000 | $0.20 | Discretionary |
| Jan 8, 2018 | ZOM | $24.8K | Option Exercise | 124,000 | $0.20 | Discretionary |